The Korean Rectal Cancer Multidisciplinary Committee Clinical Practice Guidelines for Rectal Cancer version 2.0
Authors:
- Hyo Seon RyuHRHyo Seon Ryu
- Hyun Jung KimHKHyun Jung Kim
- Dong Hyun KangDKDong Hyun Kang
- Yoo-Kang KwakYKYoo-Kang Kwak
- Han Deok KwakHKHan Deok Kwak
- Yoon-Hye KwonYKYoon-Hye Kwon
- Dalyon KimDKDalyon Kim
- Baek-Hui KimBKBaek-Hui Kim
- Jae Hyun KimJKJae Hyun Kim
- Ji Hun KimJKJi Hun Kim
- Jin Won KimJKJin Won Kim
- Tae Hyung KimTKTae Hyung Kim
Open Access
- 28 February 2026
- journal article
- guideline
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 42 (1) , 4-33
Abstract
Rectal cancer, which accounts for approximately 40% of colorectal cancers, remains a major clinical concern. Recent advances in diagnostic imaging, surgical techniques, radiotherapy, and systemic treatment have steadily improved rectal cancer outcomes. Considering this, the Korean Rectal Cancer Multidisciplinary (KRCM) Committee has aimed to provide clinicians and policymakers with up-to-date, evidence-based clinical practice guidelines to support optimal decision-making, reflecting current evidence, the Korean healthcare context, and patient values and preferences. The Clinical Practice Guidelines for Rectal Cancer version 2.0 were developed through multidisciplinary collaboration with related academic societies, building upon and updating the KRCM Clinical Practice Guidelines version 1.0 (titled “Multidisciplinary guidelines for the management of rectal cancer”). These consensus guidelines of the KRCM were established based on a comprehensive literature review, evidence synthesis, with recommendation development guided by the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology, and consideration of applicability in real-world clinical practice under the national health insurance system. Each recommendation has been presented with its strength and level of evidence.Keywords
Funding Information
- National Cancer Center (NCC-2112570-4)
This publication has 308 references indexed in Scilit:
- Time Interval Between the End of Neoadjuvant Therapy and Elective Resection of Locally Advanced Rectal Cancer in the CRONOS StudyJAMA Surgery, 2023
- Association of Delayed Surgery With Oncologic Long-term Outcomes in Patients With Locally Advanced Rectal Cancer Not Responding to Preoperative ChemoradiationJAMA Surgery, 2021
- Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of InterventionsCochrane Database of Systematic Reviews, 2019
- Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or RadiotherapyJAMA Surgery, 2019
- Long-term Oncological and Functional Outcomes of Chemoradiotherapy Followed by Organ-Sparing Transanal Endoscopic Microsurgery for Distal Rectal CancerJAMA Surgery, 2019
- Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and ResectionJAMA Oncology, 2018
- Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancerBritish Journal of Surgery, 2018
- Adjuvant chemotherapy in rectal cancer: Defining subgroups who may benefit after neoadjuvant chemoradiation and resection: A pooled analysis of 3,313 patientsInternational Journal of Cancer, 2014
- Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapyBritish Journal of Surgery, 2012
- Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancerBritish Journal of Surgery, 2006